1. Home
  2. QD vs NGNE Comparison

QD vs NGNE Comparison

Compare QD & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QD
  • NGNE
  • Stock Information
  • Founded
  • QD 2014
  • NGNE 2003
  • Country
  • QD China
  • NGNE United States
  • Employees
  • QD N/A
  • NGNE N/A
  • Industry
  • QD Finance: Consumer Services
  • NGNE Biotechnology: Pharmaceutical Preparations
  • Sector
  • QD Finance
  • NGNE Health Care
  • Exchange
  • QD Nasdaq
  • NGNE Nasdaq
  • Market Cap
  • QD 433.7M
  • NGNE 352.4M
  • IPO Year
  • QD 2017
  • NGNE N/A
  • Fundamental
  • Price
  • QD $2.90
  • NGNE $22.64
  • Analyst Decision
  • QD
  • NGNE Strong Buy
  • Analyst Count
  • QD 0
  • NGNE 6
  • Target Price
  • QD N/A
  • NGNE $60.80
  • AVG Volume (30 Days)
  • QD 767.1K
  • NGNE 481.6K
  • Earning Date
  • QD 11-22-2024
  • NGNE 11-18-2024
  • Dividend Yield
  • QD N/A
  • NGNE N/A
  • EPS Growth
  • QD N/A
  • NGNE N/A
  • EPS
  • QD 0.03
  • NGNE N/A
  • Revenue
  • QD $32,502,011.00
  • NGNE $925,000.00
  • Revenue This Year
  • QD N/A
  • NGNE N/A
  • Revenue Next Year
  • QD N/A
  • NGNE N/A
  • P/E Ratio
  • QD $107.77
  • NGNE N/A
  • Revenue Growth
  • QD 4.27
  • NGNE N/A
  • 52 Week Low
  • QD $1.52
  • NGNE $14.41
  • 52 Week High
  • QD $3.20
  • NGNE $74.49
  • Technical
  • Relative Strength Index (RSI)
  • QD 57.11
  • NGNE 40.23
  • Support Level
  • QD $2.76
  • NGNE $21.34
  • Resistance Level
  • QD $3.07
  • NGNE $25.35
  • Average True Range (ATR)
  • QD 0.18
  • NGNE 2.14
  • MACD
  • QD -0.05
  • NGNE 0.88
  • Stochastic Oscillator
  • QD 68.85
  • NGNE 38.64

About QD Qudian Inc. each representing one

Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.

About NGNE Neurogene Inc.

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Share on Social Networks: